Jose-mario Chichi-Capo

Toronto, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 48 publications

A Novel PDZRN3::BRAF Fusion as Potential Driver Mechanism in BAP1-inactivated Melanocytoma.

A Novel PDZRN3::BRAF Fusion as Potential Driver Mechanism in BAP1-inactivated Melanocytoma.

Journal: The American Journal of dermatopathology

Published: April 17, 2026

Spatially segregated B- and T-lymphoblasts in mixed-phenotype acute leukemia with BCR::ABL1.

Spatially segregated B- and T-lymphoblasts in mixed-phenotype acute leukemia with BCR::ABL1.

Journal: Journal of hematopathology

Published: February 28, 2026

What the VAF? A guide to the interpretation of variant allele fraction, percent mosaicism, and copy number in cancer.

What the VAF? A guide to the interpretation of variant allele fraction, percent mosaicism, and copy number in cancer.

Journal: Molecular cytogenetics

Published: April 11, 2025

Real-world validation study of the LSC17 score for risk prediction in patients with newly diagnosed acute myeloid leukemia.

Real-world validation study of the LSC17 score for risk prediction in patients with newly diagnosed acute myeloid leukemia.

Journal: Haematologica

Published: March 07, 2025

Opportunistic screening for broad range of medically relevant secondary findings: Laboratory benefits and burdens.

Opportunistic screening for broad range of medically relevant secondary findings: Laboratory benefits and burdens.

Journal: Genetics in medicine : official journal of the American College of Medical Genetics

Published: January 22, 2025

FLT3 is genetically essential for ITD-mutated leukemic stem cells but dispensable for human hematopoietic stem cells.

FLT3 is genetically essential for ITD-mutated leukemic stem cells but dispensable for human hematopoietic stem cells.

Journal: Blood

Published: June 21, 2024

Opportunistic genomic screening has clinical utility: An interventional cohort study.

Opportunistic genomic screening has clinical utility: An interventional cohort study.

Journal: Genetics in medicine : official journal of the American College of Medical Genetics

Published: April 11, 2024

Genomic Characterization of Partial Tandem Duplication Involving the KMT2A Gene in Adult Acute Myeloid Leukemia.

Genomic Characterization of Partial Tandem Duplication Involving the KMT2A Gene in Adult Acute Myeloid Leukemia.

Journal: Cancers

Published: March 14, 2024

Mutations in myeloid transcription factors and activated signaling genes predict chronic myeloid leukemia outcomes.

Mutations in myeloid transcription factors and activated signaling genes predict chronic myeloid leukemia outcomes.

Journal: Blood advances

Published: November 13, 2023

The Clinical Utility of FLT3 Mutation Testing in Acute Leukemia: A Canadian Consensus.

The Clinical Utility of FLT3 Mutation Testing in Acute Leukemia: A Canadian Consensus.

Journal: Current oncology (Toronto, Ont.)

Published: November 08, 2023

Flow cytometry-based measurable residual disease (MRD) analysis identifies AML patients who may benefit from allogeneic hematopoietic stem cell transplantation.

Flow cytometry-based measurable residual disease (MRD) analysis identifies AML patients who may benefit from allogeneic hematopoietic stem cell transplantation.

Journal: Annals of hematology

Published: September 21, 2023

Outcomes of intensive and nonintensive blast-reduction strategies in accelerated and blast-phase MPN.

Outcomes of intensive and nonintensive blast-reduction strategies in accelerated and blast-phase MPN.

Journal: Blood advances

Published: September 20, 2023

Showing 1-12 of 48

Last Updated: 09/26/2026